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Summary
Background: Upper arm swelling and venous hypertension at arteriovenous ﬁstula sites, and
insufﬁciency of hemodialysis are induced by central venous lesions in chronic hemodialysis
patients. Percutaneous transluminal angioplasty (PTA) for central venous lesions is ﬁrst-choice
treatment. Cardiac function can be evaluated by measuring the acute increase in venous return
volume after PTA.
Methods: We studied 6 cases of successful PTA for central venous stenotic or occluded lesions,
and evaluated cardiac function by Swan-Ganz (SG) catheter and ultrasound echocardiography
(UCG) at pre-, post-PTA, and on the following day.
Results: Ejection fraction (EF) in 6 cases was 71.0± 5.5% on UCG. Two cases of subclavian
venous stenosis, one case of subclavian venous occlusion, and three cases of brachiocephalic
venous occlusion were enrolled. The reference diameter (RD) was 10.2± 4.9mm, % diameter-
stenosis (%DS) was 92.2± 12.2% at pre-PTA, and %DS at post-PTA was 21.7± 20.7%. There
were no signiﬁcant differences in pulmonary capillary-wedge, pulmonary artery, and right
ventricular end-diastolic pressure in SG at pre- and post-PTA. The pressure of right atrium
(RA) and cardiac output (CO) were signiﬁcantly increased by PTA (RA pressure at pre-/post-
PTA, 9.7± 2.9/11.7± 3.6mmHg, p < 0.05, CO at pre-/post-PTA 5.09± 2.07/5.45± 2.25 l/min,
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p < 0.05). There were no signiﬁcant differences in serial EF, left atrial and left ventricular
diameters on UCG. However, the short-diameter of right ventricle (RV) and RA were sig-
niﬁcantly increased at post-PTA and recovered on the following day (RV short-diameter at
pre-/post-/following-day PTA, 26.7± 3.5/32.5± 1.9/29.1± 1.7mm, p < 0.05; RA short-diameter
at pre-/post-/following-day PTA, 30.2± 4.2/36.3± 2.4/32.1± 3.6mm, p < 0.05).
Conclusions: Volume overload after PTA for central venous stenotic or occluded lesions in chronic
hemodialysis patients resulted in increased RA and RV diameters. These changes were transient
and completely recovered by the following day. PTA for central venous lesions in patients with
without clinical cardiac problems.
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Data are expressed as mean± standard deviation. Compar-normal EF can be performed
© 2011 Japanese College of C
Introduction
The number of patients presenting for hemodialysis and the
requests for access have been increasing following improve-
ments in clinical care and survival of patients with end-stage
renal disease, and increasingly diabetic nephropathy [1].
The long-termmanagement andmaintenance of the patency
of dialysis access are substantially important to maintain
the hemodialysis conditions. Involvements of the central
veins are sometimes presented on the arteriovenous ﬁstula
site and usually associated with the venous shear stress,
trauma by previous central venous cannulation and pace-
maker lead, and anatomical compression by the clavicle and
ﬁrst rib [2—5]. The severe swelling and pain of upper arm,
venous hypertension, and the insufﬁciency of hemodialysis
conditions are induced by central venous stenosis or occlu-
sion at arteriovenous ﬁstula sites in chronic hemodialysis
patients.
Endovascular interventional therapy for these central
venous lesions is the ﬁrst choice of treatment and is effec-
tive in maintaining dialysis access [6—10]. However, cardiac
overload is induced by the increasing venous return vol-
ume after release of the severe stenosis or occlusion of the
central venous lesions, and there are no reports of cardiac
function after percutaneous transluminal angioplasty (PTA)
for central venous lesions in chronic hemodialysis patients.
We studied the serial cardiac inﬂuences of PTA for central
venous lesions.
Methods
Study patients
Between October 2009 and March 2010, 6 consecutive
patients with chronic hemodialysis and central venous steno-
sis or occlusion were introduced to Kanazawa Cardiovascular
Hospital, and successfully underwent PTA. These patients
were enrolled in the present study and the lesions were
located in the subclavian vein and brachiocephalic vein.
We undertook serial examination of cardiac function by
Swan-Ganz (SG) catheterization at pre- and post-PTA, and
ultrasound echocardiography (UCG) at pre-, post-PTA, and
the following day.The central venous intervention was performed on the
following day of routine planned hemodialysis and the
cases which presented with acute or subacute occlusion
within 2 weeks, and lesions in the cephalic arch vein were
excluded.
i
b
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f
sology. Published by Elsevier Ltd. All rights reserved.
rocedure and data collection
n the central venous stenotic cases, we inserted the sheath
rom venous or artiﬁcial graft of arteriovenous ﬁstula site
n the upper arm. The control angiography was performed
nd 5F-SG catheter was advanced to measure the pres-
ure gradient of the stenotic lesion, pressure of pulmonary
apillary wedge (PCW), pulmonary artery (PA), right ven-
ricle (RV) and right atrium (RA), and cardiac output (CO).
he PTA was performed after the measurement of SG data,
nd the measurement of SG data was reexamined immedi-
tely after the PTA procedure. The ultrasound echography
or the stenotic lesion to estimate the ﬂow velocity and
CG were undertaken pre- and post-PTA procedure, and
he following day. The ultrasound echography and UCG at
ost-PTA were performed within 1 h after the PTA proce-
ure. In the central venous occlusion cases, we inserted
he sheaths from venous or artiﬁcial graft of arteriovenous
stula site on the upper arm and femoral vein. The pres-
ure gradient was measured as the difference of catheter-tip
ressure advanced from access site and femoral vein, and
G data were collected by the catheter inserted from
emoral vein in pre- and post-PTA procedure. The ﬂow veloc-
ty of the occluded lesion on ultrasound echography was
easured immediately after the initial dilatation for the
esion by the small-sized balloon in the catheter labora-
ory.
The patients received the ﬂuid drip-infusion intra-
enously at 20ml/h in 5 h during and after the PTA
rocedure. The PTA procedure was performed on the follow-
ng day after routine hemodialysis, and hemodialysis after
TA was undertaken after examination of UCG on the fol-
owing day.
The measurement methods of long and short distance in
V and RA on UCG ﬁndings are presented in Fig. 1. The dis-
ances of RV chamber were measured in 4 chamber view at
nd-diastolic phase and the distances of RA were measured
t end-systolic phase.
tatisticssons between SG data at pre- and post-PTA were performed
y the Wilcoxon signed-ranks test. The UCG parameters
mong 3 points were determined by the Tukey—Kramer test
or post hoc analysis. The value of p < 0.05 was considered
igniﬁcant.
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aigure 1 Schematic representation of measurement methods
f RV and RA on ultrasound echocardiography ﬁndings. RV, right
entricle; RA, right atrium.
esults
ase presentatione present a case with chronic heart failure and hemodial-
sis. This patient was 87 years old, female, and had mitral
alve stenosis. Her native arteriovenous ﬁstula was pro-
uced in her left forearm and she had received routine
n
a
i
t
e
igure 2 Percutaneous transluminal angioplasty for a case with
howed chronic totally occlusion of the left subclavian vein and r
ith support catheter from bidirectional approach. (C) Inﬂation of
ngiography showed good reﬂow of left subclavian vein and disappeY. Horita et al.
emodialysis for about 27 years. The upper arm swelling and
ain had increased gradually from 2 years before, and she
as diagnosed as having chronic total occlusion (CTO) of the
eft subclavian vein by angiography. She was introduced to
ur hospital for the PTA of that occluded central vein, and
he mitral valve area of this patient was 1.30 cm2 on UCG
ndings.
We inserted the 6F-sheath from the venous site of the
rteriovenous ﬁstula and the angiography presented the
otally occluded subclavian vein with rich venous collat-
ral vessels (Fig. 2A). We inserted a 5F-sheath from the
ight femoral vein and advanced the SG catheter to mea-
ure the cardiac function, and then performed the PTA
y the bidirectional approach (Fig. 2B). We could success-
ully pass the guide wire and delivered the SMART® stent
8.0mm× 40mm, Johnson & Johnson, Miami, FL, USA) with
ost-dilatation by the 6.0mm-diameter balloon (Fig. 2C).
he occluded lesion was successfully dilated and angiog-
aphy showed the disappearance of the collateral ﬂow
Fig. 2D).
The mean pressure gradient was signiﬁcantly decreased
rom 34mmHg to 1mmHg. The pressure of PA, RV, and
A, right ventricular end-diastolic pressure (RVEDP), and
O at post-PTA in this patient were increased in compari-
on with pre-PTA, however the mean pressure of PCW was
ot increased. The diameters of RA and RV were increased
fter PTA and recovered to the previous data at the follow-
ng day. The diameter of left atrium (LA) was increased in
his patient, however the diameter of left ventricle (LV) and
jection fraction (EF) did not show serial changes (Table 1).
left subclavian venous occlusion. (A) The control angiography
ich collateral venous ﬂow. (B) Advancing couple guide wires
6.0mm-diameter balloon after SMART® stenting. (D) The ﬁnal
arance of rich collateral venous ﬂow.
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Table 1 Swan-Ganz (SG) data and serial ultrasound echocardiographic ﬁndings in this patient (Case 3).
Pre-PTA Post PTA Following day
SG-catheter data
Pressure gradient of CTO lesion 34mmHg 1mmHg
PCWP (m) 39mmHg 35mmHg
PA (m) 43mmHg 50mmHg
RV (sys/dias) 67/14mmHg 78/17mmHg
RVEDP 15.5mmHg 17mmHg
RA (m) 14mmHg 16mmHg
CO 2.91 l/min 3.3 l/min
UCG data
RA diameter (long× short distance) 43mm× 32mm 47mm× 33mm 42mm× 31mm
RV diameter (long× short distance) 59mm× 29mm 64mm× 32mm 58mm× 30mm
LAD 38mm 42mm 45mm
LVDd/Ds 49/30mm 49/31mm 48/32mm
EF 69% 69% 61%
PTA, percutaneous transluminal angioplasty; PCWP, pulmonary capillary wedge pressure; PA, pulmonary artery; RV (sys/dias), right ven-
ssure
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LVDd/Ds, left ventricle dimension of diastole/systole; EF, ejection
Clinical characteristics in each patient
The clinical backgrounds of studied patients are pre-
sented in Table 2. Two males and four females were
enrolled, and basal disease was chronic glomerulonephri-
tis in two patients, polycystic kidney disease in one patient,
nephrosclerosis in two patients and diabetic nephropathy in
one patient. The culprit lesions were two subclavian venous
stenoses, a subclavian venous occlusion, and three brachio-
cephalic venous occlusions. The duration of hemodialysis
and the arm swelling are shown in Table 2.
Patient and lesion characteristics, and PTA
procedures
The average age of studied patients was 63.5± 14.2 years
and the duration of hemodialysis was 13.5± 8.5 years
(Table 3). The dosage of used contrast media for PTA
was 95.6± 44.9ml. The average reference diameter (RD)
was 10.2± 4.9mm, minimum lumen diameter (MLD) was
1.1± 1.9mm, % diameter stenosis (%DS) was 92.2± 12.2%,
and the lesion length was 25.1± 9.0mm at pre-PTA. The
ﬁnal balloon size was 8.3± 2.0mm and maximum balloon
inﬂation pressure was 12.5± 4.7 atm. %DS after PTA was
21.7± 20.7%, and the stent implantation was performed in 4
lesions and 2 Express® stents (Boston Scientiﬁc, Natick, MA,
USA) and 2 SMART® stents were delivered.
SG data pre- and post-PTA
The pressure gradient signiﬁcantly decreased from
26.8± 4.4 to 5.3± 7.1mmHg (p < 0.05), and the mean
pressure of PCW, PA, and end-diastolic pressure of RV were
not changed between pre- and post-PTA (Figs. 3 and 4).
The mean RA pressure post-PTA was signiﬁcantly increased
compared with pre-PTA (pre-, 9.7± 2.9mmHg; post-,
11.7± 3.6mmHg, p < 0.05) and CO signiﬁcantly increased
a
m
t
i
r; RA, right atrium; CO, cardiac output; LAD, left atrial dimension;
tion.
rom 5.09± 2.07 at pre-PTA to 5.45± 2.25 l/min (p < 0.05)
t post-PTA (Fig. 5).
erial UCG ﬁndings
he ﬂow velocity of the lesions signiﬁcantly decreased
n serial UCG ﬁndings (pre-, 334± 49 cm/s; post-,
42± 45 cm/s; following, 88± 30 cm/s). The sizes of
A diameter and LV diastolic diameter did not change
erially and serial ejection fractions were similar at
re-, post-PTA and on the following day (Figs. 6 and 7).
he long distance of RV at pre-/post-/following-day was
0.0± 6.2/57.5± 6.7/52.9± 4.9mm, and short distance
f RV was 26.7± 3.5/32.5± 1.9/29.1± 1.7mm (p < 0.05)
Fig. 8). The long distance of RA at pre-/post-/following-day
as 45.1± 5.1/49.4± 7.2/46.7± 8.7mm and short distance
f RA was 30.2± 4.2/36.3± 2.4/32.1± 3.6mm (p < 0.05)
Fig. 9). The long distances of RV and RA were increased
t post-PTA in comparison with pre-PTA, but there were
ot signiﬁcant differences in statistics. However, the short
istances of RV and RA at post-PTA were signiﬁcantly
ncreased compared with pre-PTA, and the enlargements of
V and RA were recovered to the initial data of pre-PTA on
he following day.
iscussion
he arm swelling, venous hypertension, and insufﬁciency of
emodialysis induced by central venous stenosis or occlusion
ave been signiﬁcantly improved by central venous inter-
ention [8—11], but the primary patency rate of central
enous intervention at 1 year follow-up is about 30% and
ssisted patency rate is about 70% [10—13]. We reviewed
any reports of the efﬁcacy of central venous interventional
herapy, however there were few reports of the cardiac
nﬂuences and occurrence of heart failure by increasing
eturn volume overload after central venous intervention.
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Table 3 Patient and lesion characteristics, and PTA
procedures.
Age (years) 63.5± 14.2
Male/female 2/4
Duration of hemodialysis (years) 13.5± 8.5
Stenosis/CTO 2/4
Dosage of used contrast-media 95.6± 44.9ml
Quantitative vessel analysis
Pre-PTA
RD 10.2± 4.9mm
MLD 1.1± 1.9mm
%DS 92.2± 12.2%
Lesion length 25.1± 9.0mm
Post-PTA
RD 10.4± 4.7mm
MLD 7.8± 1.2mm
%DS 21.7± 20.7%
PTA success rate 100%
PTA procedure
Initial ballooning
Balloon size 4.2± 3.1mm
Max. balloon pressure 14.5± 3.2 atm
Final ballooning
Balloon size 8.3± 2.0mm
Max. balloon pressure 12.5± 4.7 atm
Stenting 4 cases (2
Express® & 2
SMART® stents)
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mRD, reference diameter; MLD, minimum lumen diameter; %DS,
% diameter stenosis; CTO, chronic total occlusion.
Oe et al. [14] reported a case with high-output heart
ailure during hemodialysis, and this case was diagnosed as
aving high-output heart failure due to a high-ﬂow arte-
iovenous ﬁstula and treated by the ligation of proximal
adial artery. Otsuka et al. [15] reported that left ventric-
lar diastolic dysfunction was observed even in patients
ith early stages of chronic kidney dysfunction. The pro-
uction of arteriovenous ﬁstula or arteriovenous graft for
he patient with end-stage renal disease has the possibility
f drawing cardiac failure and left ventricular hypertrophy
ecause of increased cardiac output [16—18], and the guide-
ine of the Japanese Society for Dialysis Therapy reported
he production of arteriovenous ﬁstula for patients with
ow EF (<30%) should be observed carefully, and the high-
ow arteriovenous AV ﬁstula which presented with increased
stula ﬂow >1000ml/min or ﬁstula ﬂow/CO >0.2, some-
imes induced cardiac failure [7,14,19]. We thought that
nterventional therapy for central venous stenosis or occlu-
ion might induce the deterioration of cardiac function
ecause of the acute increase in venous return volume
imilar to previous reports about high-ﬂow. The results in
ur study demonstrated that increased cardiac output was
hown immediately after PTA, however the pressure of PCW,
A, and RV did not increased. These results indicate that
olume overload after PTA was alleviated by the enlarge-
ent of RA and RV chamber, and the changes in cardiac
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P<0 05 NSmmHg mmHg
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Pressure Gradient
Pre-PTCA Post-PTCA
Mean PCW Pressure
0
Pre-PTCA Post-PTCA
of Pre & Post-PTCA
Figure 3 Pressure gradient and PCW pressure at pre- and post-PTA. PCW, pulmonary capillary wedge; PTA, percutaneous translu-
minal angioplasty; NS, not signiﬁcant.
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27.7±12.9
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15.2±6.110 30.5±12.2
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RV End-diastolic PressureMean PA Pressure
20
10
0
Figure 4 Mean PA and RV end-diastolic pressure at pre- and post-PTA. PA, pulmonary artery; PTA, percutaneous transluminal
angioplasty; RV, right ventricle.
P<0.05
5 09±2 07
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5 45±2 25
mmHg L/min
20 9.7±2.9 11.7±3.6
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.
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Post-PTCAPre-PTCA
Cardiac Output)Mean RA Pressure
Figure 5 Mean RA pressure and cardiac output at pre- and post-PTA. PTA, percutaneous transluminal angioplasty; RA, right atrium.
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Figure 6 Flow velocity of the target lesions and LA diameter at pre-, post-PTA, and the following day on ultrasound echocardio-
graphy ﬁndings. LA, left atrium; PTA, percutaneous transluminal angioplasty.
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LV diastolic diameter Ejection fraction
Figure 7 LV diastolic diameter and ejection fraction at pre-, post-PTA, and the following day on ultrasound echocardiographic
ﬁndings. LV, left ventricle; PTA, percutaneous transluminal angioplasty.
Figure 8 Long and short distances of right ventricle at pre-, post-PTA, and the following day on ultrasound echocardiographic
ﬁndings. PTA, percutaneous transluminal angioplasty.
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ﬁndings. PTA, percutaneous transluminal angioplasty.
function after PTA were completely recovered on the fol-
lowing day as shown by serial UCG ﬁndings. But, our studied
cases presented with normal EFs and the cardiac functions
of hemodialysis patients are often disturbed with low output
and low EF. Central venous intervention for these patients
with cardiac dysfunction may induce acute cardiac fail-
ure by the acute increase of return volume, and we have
to consider the superﬁcial repositioning of the artery for
hemodialysis access and close the arteriovenous ﬁstula. The
indication for the cardiac function of the arterial superﬁcial
repositioning has been reported as low EF of 30% or below,
and the patency rate of the superﬁcial repositioning artery
was 76.5—92.6% [7,20]. This patency rate is better than
that of central venous intervention [10—13]. However, the
superﬁcial repositioning has several problems of aneurysm
formation, massive hematoma, arterial stenosis, and infec-
tion by repeated punctures, and impossibility of puncture in
2 weeks after operation.
Thinking about the volume overload, we have to consider
the ﬂuid drip-infusion and the dosage of contrast media
during this study. The ﬂuid drip-infusion was performed
intravenously as 20ml/h in only 5 h during and after PTA and
the dosage of used contrast-media was 96ml, so the total
amount of infusion was only 196ml. Patients took water and
food after PTA, and hemodialysis after PTA was performed
after examination by UCG on the following day. Namely,
excretion of the water by hemodialysis was not practiced
during the PTA procedure and collection of studied data in
all enrolled patients. However, our results showed RA and RV
dilatation immediately after PTA, which recovered on the
following day. It is suggested that the transient increase in
RA and RV diameters could be explained by volume overload
immediately after PTA for central venous lesions in chronic
hemodialysis patients.
The increased ﬂow velocity in the stenosis or occluded
lesions on the serial UCG ﬁndings signiﬁcantly decreased,
and the ﬂow velocity on the following day was signiﬁcantly
more decreased than the ﬂow velocity at post-PTA. The arm
swelling at the arteriovenous ﬁstula site gradually decreased
similar to the decrease in ﬂow velocity. The swelling of arm
was normalized within 2—3 weeks after central venous inter-
vention in our experience.-PTA, and the following day on ultrasound echocardiographic
tudy limitations
he EF of consecutive enrolled patients in this study was
bout 71% in normal range and cases with lower EF were not
tudied. The cases which present with low EF (<30%) are not
ndicated for arteriovenous ﬁstula for hemodialysis access.
e have to evaluate the cardiac inﬂuence of central venous
ntervention on hemodialysis cases with disturbed EF.
onclusions
he volume overload after PTA for central venous steno-
is or occlusion in chronic hemodialysis patients resulted
n an increase of RA and RV diameters, but the changes
ere transient and completely recovered on the following
ay. Interventional therapy for central venous lesions in the
atient with normal EF can be performed without clinical
ardiac problems.
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